MA Jun, DENG Cheng-xin. Chemoimmunotherapy with A Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2011.05.012
|
Citation:
|
MA Jun, DENG Cheng-xin. Chemoimmunotherapy with A Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2011.05.012
|
MA Jun, DENG Cheng-xin. Chemoimmunotherapy with A Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2011.05.012
|
Citation:
|
MA Jun, DENG Cheng-xin. Chemoimmunotherapy with A Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia∥[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2011.05.012
|
DownLoad: